Maxwell John T.
Insider CIK 1739025 · AQST SVP-Chief Financial Officer · WEJO Chief Financial Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| WEJO Wejo Group Ltd | F Tax w/h | 2022-11-19 | 2022-11-21 | 74,456 | $0.84 | $62.5K | 440,593 | SEC↗ |
| WEJO Wejo Group Ltd | A Award deriv | 2022-07-27 | 2022-07-29 | 12,252 | $0.13 | $1.6K | 12,252 | SEC↗ |
| WEJO Wejo Group Ltd | A Award deriv | 2022-07-27 | 2022-07-29 | 12,252 | $0.13 | $1.6K | 12,252 | SEC↗ |
| WEJO Wejo Group Ltd | A Award | 2022-07-27 | 2022-07-29 | 36,757 | $1.36 | $50.0K | 36,757 | SEC↗ |
| WEJO Wejo Group Ltd | A Award | 2022-07-27 | 2022-07-29 | 36,757 | $1.36 | $50.0K | 515,049 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2020-08-18 | 2020-08-19 | 3,000 | $8.00 | $24.0K | 150,614 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2020-03-16 | 2020-03-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2019-02-28 | 2019-03-04 | 95,000 | — | $0 | 95,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-12-06 | 2018-12-07 | 5,000 | $8.87 | $44.3K | 153,614 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-11-21 | 2018-11-26 | 10,000 | $9.80 | $98.0K | 148,614 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-07-24 | 2018-07-26 | 36,120 | — | $0 | 36,120 | SEC↗ |